A 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)- CEP of the European Pharmacopoeia monograph is often referred to as a 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)- Certificate of Suitability (COS). The purpose of a 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)- CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)- EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)- to their clients by showing that a 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)- CEP has been issued for it. The manufacturer submits a 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)- CEP (COS) as part of the market authorization procedure, and it takes on the role of a 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)- CEP holder for the record. Additionally, the data presented in the 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)- CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)- DMF.
A 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)- CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)- CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of 9,10-Secocholesta-5,7,10(19)-trien-3-ol, (3beta,5Z,7E)- suppliers with CEP (COS) on PharmaCompass.